☆ 4.7 Article

Discovery of a Series of Substituted 1H-((1,2,3-Triazol-4-yl)methoxy)pyrimidines as Brain Penetrants and Potent GluN2B-Selective Negative Allosteric Modulators

JOURNAL OF MEDICINAL CHEMISTRY (2023)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Article Biochemistry & Molecular Biology

Structural modification aimed for improving solubility of lead compounds in early phase drug discovery

Bhanuranjan Das et al.

Summary: Solubility is a crucial factor in early phase drug discovery, as many potent lead compounds fail to reach clinical trials due to low bioavailability caused by insufficient solubility. Improving solubility while maintaining potency is a challenging task for medicinal chemists. Poor solubility not only hinders in vitro and in vivo assays but also prolongs drug development time and increases costs. Various techniques, including physical, chemical, and miscellaneous methods, are used to enhance solubility. The medicinal chemistry approach of structural modification is versatile and can improve other pharmacokinetic/physicochemical parameters simultaneously.

BIOORGANIC & MEDICINAL CHEMISTRY (2022)

添加到收藏夹

Review Pharmacology & Pharmacy

Novel Antidepressants in the Pipeline (Phase II and III): A Systematic Review of the US Clinical Trials Registry

Hitoshi Sakurai et al.

Summary: This study systematically searched for antidepressant compounds with completed phase II and III trials and identified nine compounds that showed positive results, including those with novel mechanisms of action. If preliminary results are confirmed, these compounds are expected to provide more options for the treatment of depression.

PHARMACOPSYCHIATRY (2022)

添加到收藏夹

Review Clinical Neurology

Novel Glutamatergic Modulators for the Treatment of Mood Disorders: Current Status

Ioline D. Henter et al.

Summary: The efficacy of standard antidepressants is limited for many patients with mood disorders, highlighting the urgent need for novel therapeutics. Both clinical and preclinical studies have suggested dysfunction in the glutamatergic system plays a role in the pathophysiology of mood disorders, with ketamine and similar glutamatergic modulators showing rapid reduction in depressive symptoms.

CNS DRUGS (2021)

添加到收藏夹

Article Chemistry, Medicinal

Design, Synthesis, and Preclinical Evaluation of 3-Methyl-6-(5-thiophenyl)-1,3-dihydro-imidazo[4,5-b]pyridin-2-ones as Selective GluN2B Negative Allosteric Modulators for the Treatment of Mood Disorders

Christa C. Chrovian et al.

JOURNAL OF MEDICINAL CHEMISTRY (2020)

添加到收藏夹

Article Chemistry, Medicinal

1H-Pyrrolo[3,2-b]pyridine GluN2B-Selective Negative Allosteric Modulators

Christa C. Chrovian et al.

ACS MEDICINAL CHEMISTRY LETTERS (2019)

添加到收藏夹

Article Biochemistry & Molecular Biology

Central Nervous System Multiparameter Optimization Desirability: Application in Drug Discovery

Travis T. Wager et al.

ACS CHEMICAL NEUROSCIENCE (2016)

添加到收藏夹

Article Chemistry, Medicinal

CNS Drug Design: Balancing Physicochemical Properties for Optimal Brain Exposure

Zoran Rankovic

JOURNAL OF MEDICINAL CHEMISTRY (2015)

添加到收藏夹

Review Neurosciences

NMDA Receptor Function During Senescence: Implication on Cognitive Performance

Ashok Kumar

FRONTIERS IN NEUROSCIENCE (2015)

添加到收藏夹

Article Pharmacology & Pharmacy

Development of a Physiologically-Based Pharmacokinetic Model of the Rat Central Nervous System

Raj Badhan et al.

Pharmaceutics (2014)

添加到收藏夹

Article Chemistry, Medicinal

Improvement in Aqueous Solubility in Small Molecule Drug Discovery Programs by Disruption of Molecular Planarity and Symmetry

Minoru Ishikawa et al.

JOURNAL OF MEDICINAL CHEMISTRY (2011)

添加到收藏夹

Article Biochemistry & Molecular Biology

Defining Desirable Central Nervous System Drug Space through the Alignment of Molecular Properties, in Vitro ADME, and Safety Attributes

Travis T. Wager et al.

ACS CHEMICAL NEUROSCIENCE (2010)

添加到收藏夹

Review Pharmacology & Pharmacy

Glutamate Receptor Ion Channels: Structure, Regulation, and Function

Stephen F. Traynelis et al.

PHARMACOLOGICAL REVIEWS (2010)

添加到收藏夹

Review Psychiatry

Glutamatergic Modulators: The Future of Treating Mood Disorders?

Carlos Zarate et al.

HARVARD REVIEW OF PSYCHIATRY (2010)

添加到收藏夹

Review Chemistry, Medicinal

Generation of a set of simple, interpretable ADMET rules of thumb

M. Paul Gleeson

JOURNAL OF MEDICINAL CHEMISTRY (2008)

添加到收藏夹

Review Neurosciences

Novel drugs and therapeutic targets for severe mood disorders

Sanjay J. Mathew et al.

NEUROPSYCHOPHARMACOLOGY (2008)

添加到收藏夹

Review Pharmacology & Pharmacy

NMDA receptor subunits: function and pharmacology

Pierre Paoletti et al.

CURRENT OPINION IN PHARMACOLOGY (2007)

添加到收藏夹

Review Neurosciences

Ionotropic and metabotropic glutamate receptor structure and pharmacology

JNC Kew et al.

PSYCHOPHARMACOLOGY (2005)

添加到收藏夹

Article Biochemical Research Methods

Automated assignment of high-resolution collisionally activated dissociation mass spectra using a systematic bond disconnection approach

AW Hill et al.

RAPID COMMUNICATIONS IN MASS SPECTROMETRY (2005)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.